News & Updates

Patients with maple syrup urine disease (MSUD) have lower levels of docosahexaenoic acid (DHA), resulting from inadequate dietary intake and change in n-3 polyunsaturated fatty acid (PUFA) metabolism, according to a study.

Use of proton pump inhibitors (PPIs) results in improvements in nighttime heartburn and reflux-related sleep disturbances, particularly in patients with reflux-driven nocturnal symptoms, a study has shown.

In the treatment of patients with Parkinson disease (PD), nicotinamide riboside does not appear to confer beneficial effects and is even associated with worse clinical outcomes compared with placebo, according to a phase III trial.

Treatment with tozorakimab as an add-on to inhaled maintenance therapy helps lessen the frequency of moderate or severe chronic obstructive pulmonary disease (COPD) exacerbations, and this benefit is observed in both former and current smokers.

Older patients with major depressive disorder (MDD) treated with active theta-burst stimulation (TBS) show no significantly greater reduction in Hamilton Depression Rating Scale (HAM-D) scores than those who received sham stimulation at week 6, according to a study.

Magnetic seizure therapy (MST) and electroconvulsive therapy (ECT) deliver similar effects on clinical outcomes in individuals with bipolar depression, reveals a study. However, MST is associated with fewer cognitive adverse effects.

In breast cancer survivors receiving aromatase inhibitors, vulvovaginal fractional carbon dioxide (CO2) laser therapy (CLT) does not appear to confer additional improvements in sexual or vaginal health outcomes, as shown in a study.